New GPC Inc. Recalls Alcosulph Moisturizing Cream for Labeling Deficiencies
New GPC Inc. is recalling Alcosulph Moisturizing Cream because it lacks required OTC drug listings and labeling, and is marked not approved for sale in the U.S.
The agency’s classification
FDA (Drugs): Class II
Class II is a situation in which use of or exposure to a violative product may cause temporary or medically reversible adverse health consequences, or where the probability of serious adverse health consequences is remote.
This is the agency’s own classification, taken from its notice. The severity score below is our assessment, not the agency’s. How recall classes work
What this means for you
Our assessment, not the agency’s: severity 2/5 (Moderate).
Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.
Our severity reasoning: The recall is classified as FDA Class II and involves minor labeling errors and regulatory non-compliance without reports of injury or illness, fitting the Moderate severity criteria.
Plain-English summary
New GPC Inc. has initiated a recall of Alcosulph Moisturizing Cream, 60g, due to regulatory non-compliance. The product is packaged in a plastic container within a small carton and originates from Guyana.
The recall is necessary because the product does not meet monograph requirements. Specifically, it lacks a drug listing, fails to meet OTC drug labeling requirements, and is labeled as not approved for sale in the U.S.A.
The recall involves 690 units distributed in New York. Affected batch numbers are 201158, 307056, and 311457. Consumers should stop using the product and follow instructions from the recalling firm or the FDA.
The recalled product
- Product
- alcosulph Moisturizing Cream, Net Contents: 60g. Product packaged within a plastic container individually placed in small carton. Country of Origin Guyana.
- Manufacturer
- New Gpc Inc.
- Category
- Drug — Over-the-Counter
- Affected units
- 690
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (3)
- Batch Numbers: 201158
- 307056
- 311457
Distribution
Distributed in 1 state:
Part of a larger recall action
This product is one of 7 recalled by New Gpc Inc. under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 7 products in this recall →Related recalls
Same manufacturer · New Gpc Inc.
See all →- ModerateNew Gpc Inc. Recalls Mustarcreme for Labeling and Listing Deficiencies
FDA (Drugs) · 2014-10-29
- ModerateNew GPC Inc. Recalls Alcosulph Astringent Lotion for Labeling Deficiencies
FDA (Drugs) · 2014-10-29
- ModerateNew Gpc Inc. Recalls Rector's Remedy Ointment for Labeling Deficiencies
FDA (Drugs) · 2014-10-29
- ModerateNew GPC Inc. Recalls Whitfield Lotion for Labeling Deficiencies
FDA (Drugs) · 2014-10-29
- ModerateNew GPC Inc. Recalls Ferrol Expectorant for Labeling Deficiencies
FDA (Drugs) · 2014-10-29
Same hazard · mis labeling
See all →- SevereWhite Vein Advanced Alkaloids Chewable Tablets Recall for Excess Active Ingredient
FDA (Food) · 2026-10-14
- HighJ K Patisserie Chocolate Chip Cookies Recalled for Undeclared Soy
FDA (Food) · 2026-10-14
- HighFreshPoint Recalls Cranberry Chicken Salad Wedges for Undeclared Egg Allergen
FDA (Food) · 2026-10-14
- HighJ K Patisserie & Bakery LLC Recalls Croissants for Undeclared Egg
FDA (Food) · 2026-10-14
- LowMindray ePM Series Patient Monitor Manuals Recalled for Alarm Clarification
FDA (Devices) · 2026-10-14
Similar recalls
- ModerateGeritrex Recalls Unapproved Carbo-O-Philic 40 Cream Tubes Nationwide
FDA (Drugs) · 2015-12-09
- ModerateHydrocortisone Cream Recalled for Lack of Processing Control
FDA (Drugs) · 2020-04-22
- LowG & W Laboratories Recalls Ciclopirox Olamine Cream Due to Outdated Insert
FDA (Drugs) · 2017-04-12
- SevereFDA Recalls G.A.C. 375 Injection Due to Unregistered Manufacturer
FDA (Drugs) · 2014-08-13
- ModerateMoisturizing skin cream recalled over contamination found at the manufacturing facility
FDA (Drugs) · 2025-11-26
- SevereAcetyl-L-Carnitine Injectable Recalled Due to Sterility Assurance Concerns
FDA (Drugs) · 2015-09-23